Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Deficit Accumulated
Beginning balance (in shares) at Dec. 31, 2022		10,518,539
Beginning balance at Dec. 31, 2022	$ 18,111	$ 11	$ 153,872	$ (135,772)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercised of stock options (in shares)	713	713
Exercised of stock options	$ 1		1
Issuance of common stock for cash, net of issuance cost (in shares)		8,323,218
Issuance of common stock for cash, net of issuance cost	35,598	$ 8	35,590
Exercise of pre-funded warrants(in shares)		3,202,785
Exercise of pre-funded warrants	3	$ 3
Share-based compensation	2,546		2,546
Net loss	(29,491)			(29,491)
Ending balance (in shares) at Dec. 31, 2023		22,045,255
Ending balance at Dec. 31, 2023	$ 26,768	$ 22	192,009	(165,263)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercised of stock options (in shares)	81,699
Issuance of common stock for cash, net of issuance cost (in shares)		21,626,191
Issuance of common stock for cash, net of issuance cost	$ 28,591	$ 22	28,569
Share-based compensation	5,303		5,303
Issuance of common stock under equity plan awards (in shares)		300,176
Issuance of common stock under equity plan award	307		307
Net loss	(41,843)			(41,843)
Ending balance (in shares) at Dec. 31, 2024		43,971,622
Ending balance at Dec. 31, 2024	$ 19,126	$ 44	$ 226,188	$ (207,106)